首页> 中文期刊>中国科学 >Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes

Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes

     

摘要

Being infected by SARS-CoV-2 may cause damage to multiple organs in patients, such as the lung, liver and heart. Angiotensin-converting enzyme 2(ACE2), reported as a SARS-CoV-2 receptor, is also expressed in human male testes. This suggests a potential risk in human male reproductive system. However, the characteristics of ACE2-positive cells and the expression of other SARS-CoV-2 process-related genes are still worthy of further investigation. Here, we performed singlecell RNA seq(scRNA-seq) analysis on 853 male embryo primordial germ cells(PGCs) and 2,854 normal testis cells to assess the effects of the SARS-CoV-2 virus on the male reproductive system from embryonic stage to adulthood. We also collected and constructed the scRNA-seq library on 228 Sertoli cells from three non-obstructive azoospermia(NOA) patients to assess the effects at disease state. We found that ACE2 expressing cells existed in almost all testis cell types and Sertoli cells had highest expression level and positive cells ratio. Moreover, ACE2 was also expressed in human male PGCs. In adulthood, the level of ACE2 expression decreased with the increase of age. We also found that ACE2 positive cells had high expressions of stress response and immune activation-related genes. Interestingly, some potential SARS-CoV-2 process-related genes such as TMPRSS2, BSG, CTSL and CTSB had different expression patterns in the same cell type. Furthermore, ACE2 expression level in NOA donors’ Sertoli cells was significantly decreased. Our work would help to assess the risk of SARS-CoV-2 infection in the male reproductive system.

著录项

  • 来源
    《中国科学》|2020年第7期|P.1006-1015|共10页
  • 作者单位

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

    Department of Urology Peking University Third Hospital Beijing 100191 China;

    Center for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

    Center for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaNational Clinical Research Center for Obstetrics and Gynecology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaNational Clinical Research Center for Obstetrics and Gynecology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 China;

    Beijing Advanced Innovation Center for Genomics Department of Obstetrics and Gynecology Third Hospital College of Life Sciences Peking University Beijing 100871 ChinaCenter for Reproductive Medicine Department of Obstetrics and Gynecology Peking University Third Hospital Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology Beijing 100191 ChinaNational Clinical Research Center for Obstetrics and Gynecology Beijing 100191 ChinaKey Laboratory of Assisted Reproduction(Peking University) Ministry of Education Beijing 100191 ChinaPeking-Tsinghua Center for Life Sciences Academy for Advanced Interdisciplinary Studies Peking University Beijing 100871 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 R698.2;
  • 关键词

    SARS-CoV-2; COVID-19; testis cells; ACE2; TMPRSS2; fetal; adult; normal; NOA;

  • 入库时间 2024-01-27 11:04:44

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号